183 related articles for article (PubMed ID: 22183857)
1. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
Kinoshita Y; Chiba T;
J Gastroenterol; 2012 Apr; 47(4):377-86. PubMed ID: 22183857
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study.
Kinoshita Y; Chiba T;
Intern Med; 2011; 50(20):2269-76. PubMed ID: 22001450
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
4. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
[TBL] [Abstract][Full Text] [Related]
6. Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial.
Amini M; Ghamar Chehreh ME; Khedmat H; Valizadegan G; Babaei M; Darvishi A; Taheri S
J Egypt Public Health Assoc; 2012 Apr; 87(1-2):29-33. PubMed ID: 22415333
[TBL] [Abstract][Full Text] [Related]
7. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
[TBL] [Abstract][Full Text] [Related]
8. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
Hongo M; Kinoshita Y; Haruma K
J Gastroenterol; 2008; 43(6):448-56. PubMed ID: 18600389
[TBL] [Abstract][Full Text] [Related]
10. Famotidine in the treatment of gastritis.
Miwa T; Miyoshi A
Scand J Gastroenterol Suppl; 1987; 134():46-50. PubMed ID: 2889258
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
14. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis.
Ohara S; Haruma K; Kinoshita Y; Kusano M
J Gastroenterol; 2010 Dec; 45(12):1219-27. PubMed ID: 20632193
[TBL] [Abstract][Full Text] [Related]
17. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
[TBL] [Abstract][Full Text] [Related]
18. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.
Tasch RF; Goeree R; Henke CJ; O'Brien BJ
Pharmacoeconomics; 1996 Jan; 9(1):61-75. PubMed ID: 10160088
[TBL] [Abstract][Full Text] [Related]
19. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
[TBL] [Abstract][Full Text] [Related]
20. Discriminant value of Rome III questionnaire in dyspeptic patients.
Abid S; Siddiqui S; Jafri W
Saudi J Gastroenterol; 2011; 17(2):129-33. PubMed ID: 21372351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
